Showing results (391-400 of 1,873) with videos related to
Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|August 21, 2020
The proliferative and anti-apoptosis functions of KGF/KGFR contributes to bronchial epithelial repair in asthmaJiongbo Wang, Hongju Sun, Yunshun LiuPulmonary Pharmacology & Therapeutics|August 1, 1997
Characterization of endothelin release from guinea-pig tracheal epithelium: influence of proinflammatory mediators including major basic proteinD W Hay, M R Van Scott, R M MuccitelliPulmonary Pharmacology & Therapeutics|August 1, 1997
Pre-junctional stimulatory and post-junctional inhibitory effects of pinacidil in the isolated main pulmonary artery of the rabbit under different experimental conditionsD Rácz, S Zillikens, P Forstreuter, et al.Pulmonary Pharmacology & Therapeutics|August 1, 1997
Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devicesB J Lipworth, D J ClarkPulmonary Pharmacology & Therapeutics|June 20, 2012
Calpain and MARCKS protein regulation of airway mucin secretionW Randall Lampe, Joungjoa Park, Shijing Fang, et al.Pulmonary Pharmacology & Therapeutics|July 11, 2012
Passive stiffness of airway smooth muscle: the next target for improving airway distensibility and treatment for asthma?Chun Y SeowPulmonary Pharmacology & Therapeutics|April 12, 2015
Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatmentIan P Hall, Andrew V Fowler, Abhya Gupta, et al.Pulmonary Pharmacology & Therapeutics|June 15, 2014
Airway and systemic oxidant-antioxidant dysregulation in asthma: a possible scenario of oxidants spill over from lung into bloodA Nadeem, N Siddiqui, Naif O Alharbi, et al.Pulmonary Pharmacology & Therapeutics|February 3, 2015
Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trialIwona Stelmach, Agata Ożarek-Hanc, Magdalena Zaczeniuk, et al.Pulmonary Pharmacology & Therapeutics|February 15, 2015
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPDA M Kirsten, K Förster, E Radeczky, et al.Pageof 188